Evaluation in STEMI Patients Using FDY-5301

Clinical trial NCT04837001 · COMPLETED

Trial details

NCT number: NCT04837001
Sponsor: Faraday Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myocardial Infarction STEMI Percutaneous Coronary Revascularization

Start date: 2022-05-02
Primary completion: 2025-09-03
Enrollment: 2351

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.